[144] DXC Technology Company SEC Filing

Rhea-AI Filing Summary

DXC Technology (Form 144): This notice reports a proposed sale of 2,500 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $36,287.53 and an approximate sale date of 09/11/2025 on the NYSE. The shares were acquired on 05/23/2024 via restricted stock vesting as compensation. The filing also discloses a prior sale of 2,500 shares on 06/11/2025 generating gross proceeds of $39,836.03. The filing omits the issuer name and filer CIK/CCC details in the provided text.

Insights

Securities Analyst

TL;DR: Routine insider sale of a small block of vested shares; transparency maintained but immaterial to market cap.

The filing documents an insider's proposed sale of 2,500 shares acquired by restricted stock vesting and lists the broker and exchange. Relative to the stated outstanding shares (178,998,669), the proposed sale is de minimis and unlikely to affect valuation. The disclosure of acquisition date and nature (compensation) aids interpretability. Missing issuer and filer identifiers in the provided text reduce completeness for automated processing.

Compliance/Risk Analyst

TL;DR: Filing meets Rule 144 disclosure elements shown here but incomplete metadata could hinder regulatory tracking.

The notice includes required transactional detail: class, broker, quantity, aggregate value, acquisition method, and prior sales within three months. These elements support compliance with Rule 144. However, the provided extract lacks explicit filer CIK/CCC and issuer name fields, which are important for registry matching and audit trails. No statements of undisclosed material nonpublic information are indicated in the text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2500	36287.53	178998669	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/23/2024	Restricted Stock Vesting	Issuer			2500	05/23/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher A. Voci 20408 Bashan Drive, Suite 231 Ashburn VA 20147	Common	06/11/2025	2500	39836.03

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DXC Form 144 report?

The filing reports a proposed sale of 2,500 common shares via Fidelity with aggregate market value $36,287.53 and an approximate sale date of 09/11/2025 on the NYSE.

How were the DXC shares acquired that are being sold?

The shares were acquired on 05/23/2024 through restricted stock vesting and the payment nature is listed as compensation.

Has the seller made other recent sales of DXC stock?

Yes. The filing discloses a prior sale of 2,500 common shares on 06/11/2025 that produced gross proceeds of $39,836.03.

How material is the proposed sale relative to DXC's outstanding shares?

The proposed sale of 2,500 shares is negligible relative to the reported 178,998,669 shares outstanding, indicating immaterial size.

Is there any indication of undisclosed material information in the filing?

The signer represents they do not know any material adverse information not publicly disclosed; the extracted text does not show any disclosed material nonpublic information.